Fintech

Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

Prnewswire·April 10, 2026 at 12:00 PM

/PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

CFTC Names Task Force for AI Rules
PYMNTS
Walmart Marketplace Drives General Merchandise Growth
PYMNTS
Fed finds stablecoins idle, confirms usage gap
PYMNTS
Judge blocks Arizona criminal charges against Kalshi
CoinDesk

Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

CFTC Names Task Force for AI Rules

Walmart Marketplace Drives General Merchandise Growth

Fed finds stablecoins idle, confirms usage gap

Judge blocks Arizona criminal charges against Kalshi